00168b2c559c82df3a2e812e566e5b1c *DESCRIPTION
edcfb3b29d3fc74d838d6268d1df41be *INDEX
1d1b14bd9637dd9cdbd5cbc0fdf17815 *Meta/Rd.rds
12ed0e180b77883de01755a3d466994c *Meta/data.rds
50a9fa3e1aa2c47fa7bdbd6e6bb8974e *Meta/features.rds
2da60dbb3c4d50f9f8cf51ee85b54e5d *Meta/hsearch.rds
1bd19fb09e9fed100c577ac3fa11217e *Meta/links.rds
676ec0720d54c3e317bf9cde6dee7294 *Meta/nsInfo.rds
fdae2940f262741261901992e721f0f7 *Meta/package.rds
75d1578da1bdab43c360375752384a5d *Meta/vignette.rds
96e2d5b61cbea0ffcebdc747d37dfb54 *NAMESPACE
8f81129b4e43d49161b03954bb68c08c *NEWS.md
d6c68f1fe41ced6e98a766a3757313da *R/nlmixr2lib
2e3602b0120b5a2aa2db3c5fdd149940 *R/nlmixr2lib.rdb
0d2493627a4eac5b1fd758757588122b *R/nlmixr2lib.rdx
b14364b08b5ae16e4afffb00555ef268 *WORDLIST
b55a00ba61090ea88ca251c5c9c401a6 *data/Rdata.rdb
dd060df40092612de86cd91abf2b1959 *data/Rdata.rds
6b95d072840e72e679c9492fb5488f9e *data/Rdata.rdx
43f6f19aba9e9c0d70d5012c95a6aa49 *doc/create-model-library.R
5c6f8bca5ff453cc64525d72a335847a *doc/create-model-library.Rmd
ea54fd08c04dcb4292ea8b7bbc981cec *doc/create-model-library.html
21d1b4dbe3b5e282c06476763149dfb4 *doc/index.html
2c73584e59f642379a6a8dba2cc7166f *doc/list-of-models.R
77378800a842961d6b7fdbf28e5ffbb4 *doc/list-of-models.Rmd
b795eff704825e137a103622403ae3a3 *doc/list-of-models.html
958659ded8617d9ca247d86d0793ae0c *help/AnIndex
7b6c267aa1f451df98f7a765b07d45fd *help/aliases.rds
b6855f1cf22c923970a6f30e30f2ed5d *help/nlmixr2lib.rdb
7e22e783ada0829510f42544f25f7bdb *help/nlmixr2lib.rdx
02e190c98668cb6b34b7e51c805a03e3 *help/paths.rds
1c57bea291a79dab7a05ae204c1d6c24 *html/00Index.html
ee41876c0116916bb04bcf4fe3e43d78 *html/R.css
61ca926eeeb90647a0421efd712173ed *modeldb/PK_1cmt.R
cff5a39e92a41b890c1bd5f5f7137266 *modeldb/PK_1cmt_des.R
b899d29dfceeff90ca56d46df2240768 *modeldb/PK_2cmt.R
68fe5e47bb99ccf9f3cbe0c2d7026b0b *modeldb/PK_2cmt_des.R
61c8f79ddf758a74625d19e4e2bee562 *modeldb/PK_2cmt_no_depot.R
105a95586da5ba90638086f4897b2412 *modeldb/PK_2cmt_tdcl_des.R
5690eebedf2056e5e3d12cfab567b777 *modeldb/PK_3cmt.R
4197f3a53244febc119ca9a1c72fae21 *modeldb/PK_3cmt_des.R
852f1c9042000c4458bc4d87f86df998 *modeldb/endogenous/phenylalanine_charbonneau_2021.R
2bd88171e99e5506c12bf4dd8fddbd86 *modeldb/pharmacodynamics/indirect_0cpt_transitEx.R
134b54b3c5994d4685314334323fa1b3 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin.R
b55383102241b9935776139b7360c3d7 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin_CLV.R
93f00eda2e48ca6791094f640af05fc2 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kin_r0rmaxcrmax.R
8faab6b392c04b364decfc13b90162a7 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout.R
177d3b40267c06ce88cf223be78a0b55 *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout_CLV.R
6e0815eac0dd72f0ec85831be1bd9f5a *modeldb/pharmacodynamics/indirect_1cpt_inhi_kout_r0rmaxcrmax.R
77feda9627d66fd0317b07dc2665b88e *modeldb/pharmacodynamics/indirect_1cpt_stim_kin.R
1e8d008acaf0d0e49afabbe6c4668a5b *modeldb/pharmacodynamics/indirect_1cpt_stim_kin_CLV.R
cd8bf22d5916027411ecb609dfaa996c *modeldb/pharmacodynamics/indirect_1cpt_stim_kin_r0rmaxcrmax.R
f00dd551d303f12392e27145bfa0bc51 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout.R
d6104ced55a4434d14729f934f01c236 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout_CLV.R
9e0fff4209e2a00007bfa707728227f7 *modeldb/pharmacodynamics/indirect_1cpt_stim_kout_r0rmaxcrmax.R
8da530df519f4cbbbedeaa72053834cf *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kin_kin_t.R
d53c1645d5aeda20a95739199d6e6133 *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kin_kout_t.R
4069fab1266e43d8999000181cab5f79 *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kout_kin_t.R
df0b64a19634c6632e260d12d09bc988 *modeldb/pharmacodynamics/indirect_circ_1cpt_inhi_kout_kout_t.R
bb1dd420dffe1a4925d536128b3272d9 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kin_kin_t.R
f398e58a52e8ac4e57b21f2f2e017cda *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kin_kout_t.R
509df83673fe100b35c1e141dc51be47 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kout_kin_t.R
b72fa1a83d6d368f34b4b0b198d29aa1 *modeldb/pharmacodynamics/indirect_circ_1cpt_stim_kout_kout_t.R
d69dd516cd444babe91f5909dd2529cf *modeldb/pharmacodynamics/indirect_prec_1cpt_inhi_CLV.R
2277961e37815f19d88a3402a3fe9f5a *modeldb/pharmacodynamics/indirect_prec_1cpt_inhi_r0rmaxcrmax.R
9f10cf38178d1e4a87dcce2c085c650b *modeldb/pharmacodynamics/indirect_prec_1cpt_stim_CLV.R
2a859e50ad2d76d7a51c3a8fe02e5149 *modeldb/pharmacodynamics/indirect_prec_1cpt_stim_r0rmaxcrmax.R
9c5c473a2b7bff1129fff46bdc4f0220 *modeldb/pharmacokinetics/PK_2cmt_mAb_Davda_2014.R
22828c8d0c0ad4fdfb5e3225dbfeebe6 *modeldb/pharmacokinetics/PK_double_sim_01.R
55f78184c9ec5517b7ad83821b6b1194 *modeldb/pharmacokinetics/PK_double_sim_10.R
ab65cb2a68468877361e01bba51dba91 *modeldb/pharmacokinetics/PK_double_sim_11.R
adcc43f3a4f88a8d76e7bfa57273d604 *modeldb/specificDrugs/CarlssonPetri_2021_liraglutide.R
ed8d76ce1b0a06990cefd1fa2b97a900 *modeldb/specificDrugs/Cirincione_2017_exenatide.R
33076601badb4e52e5039e178c061e87 *modeldb/specificDrugs/Kovalenko_2020_dupilumab.R
9777378994c57f1e2dc2294ddeb34fea *modeldb/specificDrugs/Soehoel_2022_tralokinumab.R
33283dbae268619b149385e69ee037d8 *modeldb/specificDrugs/Zhu_2017_lebrikizumab.R
714a044237110ec04d85c5ea52c76303 *modeldb/therapeuticArea/oncology/oncology_sdm_lobo_2002.R
fb8f7ff43debc576fbdfd52b88c2f9ec *modeldb/therapeuticArea/oncology/oncology_xenograft_simeoni_2004.R
15039d27cb0b75bd19ac2c00d89589b8 *modeldb/therapeuticArea/oncology/tgi_no_sat_Koch.R
bc3de136643af6bb7ff7d27c96d75f88 *modeldb/therapeuticArea/oncology/tgi_no_sat_expo.R
dd340d07d5f3163e6a58d0ca2ba057f4 *modeldb/therapeuticArea/oncology/tgi_no_sat_linear.R
d7065a2d34a919b3dd742d8625359e91 *modeldb/therapeuticArea/oncology/tgi_no_sat_powerLaw.R
c82e583e771c63ac4e480352cf13e829 *modeldb/therapeuticArea/oncology/tgi_sat_VonBertalanffy.R
e8c613c4be05327adeb3d4cb05da0276 *modeldb/therapeuticArea/oncology/tgi_sat_genVonBertalanffy.R
579c47e1fe80bb17680ebde6b3dc92b3 *modeldb/therapeuticArea/oncology/tgi_sat_logistic.R
